By univariate analysis, total bilirubin (P=0.022), prothrombin activity (P=0.027), serum ALT (P=0.018), tumor size (P=0.001), and treatment allocation (P=0.003) showed relevance to OS; meanwhile, serum AFP (P=0.041), number of tumors (P=0.024), tumor size (P=0.009), and treatment allocation (P < 0.001) showed relevance to PFS. This evidence concerns the gene F2 and neoplasm.